TCT-311 Everolimus- Versus Zotarolimus-Eluting Stent Following Percutaneous Coronary Chronic Total Occlusion Intervention

TCT-311 Everolimus- Versus Zotarolimus-Eluting Stent Following Percutaneous Coronary Chronic Total Occlusion Intervention

After multivariable adjustment, no significant difference was observed between the two groups in terms of the risk of primary outcome (Hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.59-1.79, P = 0.930 for ZES compared with EES), as well as the risks of death (adjusted HR 0.96, 95% CI 0.43-2....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-11, Vol.68 (18), p.B128-B128
Hauptverfasser: Cho, Min Soo, Kang, Do-yoon, Do, Ungjeong, Hong, Jung Ae, Lee, Kyusup, Kwon, Osung, BAE, JAESEOK, Kim, Yu Na, Lee, Cheol Hyun, Kang, Se Hun, Yoon, Sung-Han, Lee, Pil Hyung, Ahn, Jung-Min, Park, Duk-Woo, Kang, Soo-Jin, Lee, Seung-Whan, Kim, Young-Hak, Lee, Cheol Whan, Park, Seong-Wook, Park, Seung-Jung
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Stents
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:After multivariable adjustment, no significant difference was observed between the two groups in terms of the risk of primary outcome (Hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.59-1.79, P = 0.930 for ZES compared with EES), as well as the risks of death (adjusted HR 0.96, 95% CI 0.43-2.15, P = 925), death or myocardial infarction (adjusted HR 0.93, 95% CI 0.46-1.88, P = 0.829) and target vessel failure (adjusted HR 0.96, 95% CI 0.51-1.82, P = 0.902).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2016.09.441